RM
Ciloa Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| APN-sEVs | Obesity and Type 2 Diabetes | Pre-clinical |
| sEV-based Vaccines | Emerging Viral Pandemics | Pre-clinical |
| Oncology Programs | Oncology (unspecified) | Pre-clinical |
| AB-BIOBETTER Collaboration | Inflammatory Diseases (Oral Adalimumab) | Research |